<DOC>
	<DOCNO>NCT02013934</DOCNO>
	<brief_summary>The objective study assess benefit tolerability probiotic product subject increased susceptibility common cold .</brief_summary>
	<brief_title>Probiotics Prevention Common Cold</brief_title>
	<detailed_description />
	<mesh_term>Common Cold</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<criteria>male female age 1870 year increase risk common cold ( least 4 episode within 12 month ) commitment adhere former diet physical activity commitment use product may influence study outcome ( e.g . immune suppressants/immune stimulant , include paramedication e.g . Echinacea , analgesics/antirheumatics , antiphlogistics , antitussives/expectorants , influenza remedy , mouth throat therapeutic , decongestant , antibiotic , antihistaminergic drug , probiotic ) study ( except rescue medication , see 7.5 ) woman childbearing potential agree use appropriate birth control method Written consent subject participate prerequisite study participation . acute / chronic upper / low airway disease chronic cough origin allergic reaction may influence study outcome ( e.g . acute/chronic rhinitis ) history nasal reconstructive surgery presence nasal ulcer nasal polyp severe nasal septum deviation condition could cause nasal obstruction congenital acquire immunodeficiency disease ( e.g . HIV infection ) Bechterew 's disease body temperature 37.5Â°C suspected swine flu influenza vaccination vaccine contain adjuvant within 3 month prior study start study vaccination vaccine contain adjuvant within 6 week prior study start study stomach/gastrointestinal disease serious organ systemic disease sleep disorder psychiatric disorder know sensitivity ingredient investigational product regular intake product may influence study outcome ( e.g . immune suppressants/immune stimulant , include paramedication e.g . Echinacea , analgesics/antirheumatics , antiphlogistics , antitussives/expectorants , influenza remedy , mouth throat therapeutic , decongestant , antibiotic , antihistaminergic drug , probiotic ) within last 4 week prior study start habitual usage nasal drops/spray pregnancy nurse alcohol / drug abuse simultaneous participation another clinical trial participation clinical trial within last 30 day insufficient compliance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>